The Covid vaccine results are great news, but it’s not all over yet

Oxford/AstraZeneca findings have certain advantages over those from other versions

Within weeks, the prospects of an end to the pandemic have changed utterly, with three vaccines against Covid-19 reporting good results in final clinical trials and at least one likely to be used before Christmas. But there are still huge challenges ahead.

The results from the Oxford University/AstraZeneca vaccine, which is absolutely central to the UK’s vaccination strategy, may at first glance look not as good as those of Pfizer/BioNTech and Moderna – the two mRNA vaccines that have both reported 95% efficacy.

Continue reading...

Oxford AstraZeneca Covid vaccine has up to 90% efficacy, data reveals

Vaccine developed in UK by AstraZeneca and Oxford University ‘will save many lives’, says scientist

A coronavirus vaccine developed in the UK can prevent 70.4% of people from getting Covid-19 and up to 90% if a lower dose is used, according to data.

Oxford University and AstraZeneca have announced their jab is effective in preventing many people getting ill and it has been shown to work in different age groups, including the elderly. There are early indications it might also help stop the spread of the disease.

Continue reading...

G20 leaders pledge to distribute Covid vaccines fairly around world

Virtual summit an awkward swan song for Trump who skipped some sessions to play golf

G20 leaders meeting remotely pledged on Sunday to “spare no effort” to ensure the fair distribution of coronavirus vaccines worldwide, but offered no specific new funding to meet that goal.

The virtual summit hosted by Saudi Arabia was an awkward swan song for Donald Trump, who skipped some sessions on Saturday to play golf, paid little attention to other leaders’ speeches and claimed the Paris climate agreement was designed not to save the planet but to the kill the US economy.

Continue reading...

US vaccine expert predicts life could be back to normal around May

Operation Warp Speed chief says if immunization plan goes well enough Americans should be vaccinated by May

As the number of Covid-19 cases in the United States passed 12 million, the Trump administration’s vaccine program adviser predicted that life in America could be back to normal around May of 2021 as immunization is set to begin.

The note of optimism came even as millions of Americans were expected to travel for the upcoming Thanksgiving holiday this week and many appeared to be ignoring warnings from health officials about furthering the spread of the infectious disease.

Continue reading...

Is this the beginning of an mRNA vaccine revolution? | Adam Finn

No one knew whether mRNA technology would work against this virus – but it does. It’s an extraordinary moment for science

The past few months have brought a number of scientific terms to public attention. We’ve had to digest R (a virus’s reproduction number) and PCR (the polymerase chain reaction method of testing). And now there’s mRNA. This last one has featured heavily in recent news reports because of the spectacular results of two new mRNA vaccines against coronavirus. It stands for “messenger ribonucleic acid”, a label familiar enough if you studied biology at O-level or GCSE, but otherwise hardly a household name. Even in the field of vaccine research, if you had said as recently as 10 years ago that you could protect people from infections by injecting them with mRNA, you would have provoked some puzzled looks.

Essentially, mRNA is a molecule used by living cells to turn the gene sequences in DNA into the proteins that are the building blocks of all their fundamental structures. A segment of DNA gets copied (“transcribed”) into a piece of mRNA, which in turn gets “read” by the cell’s tools for synthesising proteins. In the case of an mRNA vaccine, the virus’s mRNA is injected into the muscle, and our own cells then read it and synthesise the viral protein. The immune system reacts to these proteins – which can’t by themselves cause disease – just as if they’d been carried in on the whole virus. This generates a protective response that, we hope, lasts for some time. It’s so beautifully simple it almost seems like science fiction. But last week we learned that it was true.

Continue reading...

Why the race to find Covid-19 vaccines is far from over

Despite the promising news from Pfizer and Moderna, other efforts – which may be even more effective – continue around the world

While everyone celebrated this month’s news that not one but two experimental vaccines against Covid-19 have proved at least 90% effective at preventing disease in late-stage clinical trials, research into understanding how the Sars-CoV-2 virus, which causes Covid-19, interacts with the human immune system never paused.

There are plenty of questions still to answer about the Pfizer/BioNTech and Moderna vaccines: how well will they protect the elderly, for example, and how long for? Which aspects of the immune response that they elicit are protective and which aren’t? Can even better results be achieved, with vaccines that target different parts of the immune system?

Continue reading...

Christmas in lockdown preferred by UK public over new restrictions in January

Observer/Opinium poll also finds switch in support for political leadership

Most of the public would rather have a locked-down Christmas than have a new lockdown imposed in January, a new poll suggests.

With the government considering the extent to which restrictions should be lifted to limit the impact on Christmas family gatherings, the latest Opinium poll for the Observer found that the public opted for a locked-down Christmas over new January restrictions by a margin of 54% to 33%.

Continue reading...

Covid vaccine technology pioneer: ‘I never doubted it would work’

Katalin Karikó’s mRNA research helped pave way for Pfizer/BioNTech and Moderna’s successful work

The Hungarian-born biochemist who helped pioneer the research behind the mRNA technology used in the two Covid-19 vaccines showing positive results believes it was always a no-brainer.

“I never doubted it would work,” Katalin Karikó told the Guardian. “I had seen the data from animal studies, and I was expecting it. I always wished that I would live long enough to see something that I’ve worked on be approved.”

Continue reading...

Scientists race to find ‘warm’ Covid vaccine to solve issue of cold storage

With potential injectable vaccines estimated to be out of reach for two-thirds of world’s population, scientists hope to find less-heat-sensitive formulations

News that one of the potential coronavirus vaccines had at least a 90% efficacy rate was a “victory for science”, said K Srinath Reddy, a cardiologist and president of the Public Health Foundation of India. But it meant little to his country’s 1.3 billion citizens.

“For us, the Pfizer vaccine is more of a scientific curiosity than a practical possibility,” Reddy said.

Continue reading...

Covid vaccines should not be seen as ‘unicorn’ solution, says WHO chief – video

Michael Ryan, the head of the World Health Organization’s emergencies programme, has said that while vaccines are effective tools, they are not the lone solution to ending the coronavirus pandemic.

‘Some people think that vaccines will be, in a sense, the solution, the unicorn we’ve all been chasing,’ he said during a virtual briefing in Geneva on Wednesday, warning other measures such as social distancing needed to be maintained.

It comes after positive efficacy results from late-stage trials of two potential Covid-19 vaccines

Continue reading...

Dolly Parton partly funded Moderna Covid vaccine research

The country music icon’s $1m donation supported the latest breakthrough by Moderna and several research papers

It’s truly the greatest gift of all: a $1m donation by Dolly Parton to coronavirus vaccine research supported the development of the Moderna vaccine, which shows 95% protection from the virus.

In April, Parton donated £800,000 to research after her friend Dr Naji Abumrad of the Vanderbilt Institute for Infection, Immunology and Inflammation at Vanderbilt University in Tennessee told her that they were making “some exciting advancements” in the search for a cure for the virus. Abumrad and Parton became friends in 2014 after the singer was involved in a car accident and treated at Vanderbilt.

Continue reading...

Hopes of Covid vaccine for more than 1bn people by end of 2021

Moderna becomes second firm to reveal positive results with nearly 95% protection in trials

More than 1 billion people could be immunised against coronavirus by the end of next year with shots from the first two companies to reveal positive results, after the latest vaccine was shown to be nearly 95% effective in trials.

With the US’s top infectious diseases official, Anthony Fauci, hailing “the light at the end of the tunnel”, the US biotech firm Moderna announced impressive results for its mRNA vaccine on Monday, a week after interim results for a Pfizer/BioNTech vaccine showed 90% effectiveness.

Continue reading...

Moderna vaccine’s effectiveness bodes well for Oxford/AstraZeneca jab

Phase 3 success rate of 95% for US firm’s treatment is promising for UK vaccine trial

Hopes are rising for the Covid jab being developed by Oxford University, after Moderna became the second company to reveal impressive results from its vaccine trials.

Interim results from phase 3 clinical trials of the Covid vaccine from US company Moderna has revealed it to be almost 95% effective at preventing the disease. The news followed an announcement last week from Germany-based Pfizer and BioNTech that their vaccine was more than 90% effective.

Continue reading...

Latest vaccine success is good news but high price may restrict access

Moderna results show Pfizer success was not flash in the pan, but poorer countries may have to look elsewhere

The success of Moderna’s vaccine against Covid-19 is reason for the whole world to cheer. The results from an interim analysis of the trial data are remarkably similar to those of Pfizer/BioNTech a week ago. Most people – Moderna says 94.5% in its trial, Pfizer said more than 90% – were protected from illness.

It’s fantastic news. It means the concept works. Pfizer’s results were not a flash in the pan. Both vaccines have been developed using a new technology that has never produced a licensed vaccine before, called messenger RNA (mRNA), which some hail as the future of all vaccines. It has the potential to deliver vaccines for all sorts of diseases cheaply and safely, enthusiasts say. And, crucially for the time being, they are likely to help us out of the Covid pandemic.

Continue reading...

What does the Moderna vaccine mean for the fight against Covid?

How does it work and how is it different from the Pfizer/BioNTech jab?

As promising results are released from a second vaccine trial, we take a look at what this could mean in the battle against Covid-19.

Continue reading...

A vaccine? Trump going? A bit of good news and my optimism has gone bananas

The doom spiral has been interrupted. Could it be that, by the spring, things will actually be better than they are now?

After five years of wanting to move, about two years of having to move and eight months of really urgently needing to move, the kids being so large and teen now that we could all smell each other across two floors of our titchy house, we finally moved. The sheer number of small, troublesome questions this prompted – have we traumatised the rabbit? Will the dog definitely die if he runs on to the A3, and will the resulting pile-up be legally my fault? What’s at the bottom of this pan we packed, oh God no, it’s curdled milk, who moves house without washing up first? Me, that’s who – completely clouded my vision. It was days before I realised something good had happened.

The US elections unfolded at the same time, following the same pattern. Lots of facts, and counting, and more facts, and revised counting, and nebulous fretting, until finally, wait … this is actually good. Something good has happened. This would have been a really fortuitous day to buy a lottery ticket, I thought on Saturday evening; with so much improbable good fortune, the chances of me winning a million quid are probably pretty high. I didn’t follow that up because I was too busy drinking and whatnot. Then two days later, a vaccine.

Continue reading...

Is the vaccine safe? Do I need it if I’ve had Covid? Readers’ questions answered

‘Zero chance’ mRNA can alter genes, says expert, adding that vaccine can ‘top up’ immune response from infection

“The concerted efforts put into developing a vaccine are wonderful but they can’t possibly know about long-term adverse effects. I’ll have it if it’s offered to me, and at my age long-term effects are irrelevant. I just hope it doesn’t turn out to be a latter-day thalidomide.” Jenny Walters, retired teacher, Ashburton

Continue reading...

Measles cases hit 20-year high as Covid disrupts vaccinations, report finds

Number of people dying from the disease also increased by 50% since 2016, according to data from the WHO and CDC

The number of measles cases worldwide surged to nearly 900,000 in 2019, the highest figure in more than two decades, underlining a significant U-turn in global progress to combat the disease.

Data from the World Health Organization (WHO) and US Centers for Disease Control and Prevention (CDC) found that the number of people dying from measles also increased by 50% since 2016, with an estimated 207,500 deaths in 2019 alone.

Continue reading...

‘It came in a locked box’: UK Covid vaccine volunteers – in pictures

Thousands of ordinary people around Britain volunteered to take part in the Imperial College London coronavirus vaccine trial. Who are they, what motivated them to take part, and what’s it been like?

  • These portraits were taken for Team Halo, an initiative that goes behind the scenes with the scientists trying to develop a Covid vaccine
Continue reading...

Scientist behind BioNTech/Pfizer vaccine says it can end pandemic

Exclusive: BioNTech’s CEO Uğur Şahin says he is confident vaccine can ‘bash the virus over the head’

The scientist behind the first Covid-19 vaccine to clear interim clinical trials says he is confident his product can “bash the virus over the head” and put an end to the pandemic that has held the world hostage in 2020.

The German company BioNTech and the US pharmaceutical giant Pfizer announced via a press release on Monday that their jointly developed vaccine candidate had outperformed expectations in the crucial phase 3 trials, proving 90% effective in stopping people from falling ill.

Continue reading...